ProShares Ultra Nasdaq Biotechnology (BIB)
NASDAQ: BIB · Real-Time Price · USD
86.66
+4.92 (6.02%)
At close: Feb 6, 2026, 4:00 PM EST
87.00
+0.34 (0.39%)
After-hours: Feb 6, 2026, 4:24 PM EST
BIB Holdings Information
BIB is an equity ETF with a total of 271 individual holdings.
Total Holdings
271
Top 10 Percentage
152.98%
Asset Class
Equity
ETF Category
Trading--Leveraged Equity
Assets
89.54M
PE Ratio
n/a
Sector Allocation
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | n/a | NASDAQ BIO INDEX SWAP BNP PARIBAS | 36.26% |
| 2 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA | 29.86% |
| 3 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA | 23.97% |
| 4 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL | 17.85% |
| 5 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE | 16.80% |
| 6 | GILD | Gilead Sciences, Inc. | 7.04% |
| 7 | AMGN | Amgen Inc. | 6.32% |
| 8 | VRTX | Vertex Pharmaceuticals Incorporated | 6.28% |
| 9 | REGN | Regeneron Pharmaceuticals, Inc. | 4.32% |
| 10 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG | 4.28% |
| 11 | ALNY | Alnylam Pharmaceuticals, Inc. | 2.39% |
| 12 | INSM | Insmed Incorporated | 1.76% |
| 13 | BIIB | Biogen Inc. | 1.48% |
| 14 | ARGX | argenx SE | 1.30% |
| 15 | UTHR | United Therapeutics Corporation | 1.12% |
| 16 | ILMN | Illumina, Inc. | 1.11% |
| 17 | INCY | Incyte Corporation | 1.10% |
| 18 | RPRX | Royalty Pharma plc | 1.03% |
| 19 | RVMD | Revolution Medicines, Inc. | 1.01% |
| 20 | VTRS | Viatris Inc. | 0.90% |
| 21 | MRNA | Moderna, Inc. | 0.87% |
| 22 | MEDP | Medpace Holdings, Inc. | 0.83% |
| 23 | ROIV | Roivant Sciences Ltd. | 0.80% |
| 24 | NBIX | Neurocrine Biosciences, Inc. | 0.75% |
| 25 | IONS | Ionis Pharmaceuticals, Inc. | 0.74% |
As of Feb 5, 2026